| PERIOD ENDING | 11-Sep-09 | 19-Jun-09 | 27-Mar-09 | 2-Jan-09 | | Total Revenue | 2,471,000 | 2,562,000 | 2,495,000 | 3,784,000 | | Cost of Revenue | (3,145,000) | 2,283,000 | 2,237,000 | 3,385,000 | | | Gross Profit | 5,616,000 | 279,000 | 258,000 | 399,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 5,499,000 | 146,000 | 174,000 | 270,000 | | Non Recurring | 623,000 | 33,000 | 2,000 | 55,000 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (506,000) | 100,000 | 82,000 | 74,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (134,000) | 11,000 | (11,000) | (18,000) | | Earnings Before Interest And Taxes | (652,000) | 107,000 | 37,000 | 71,000 | | Interest Expense | 27,000 | 28,000 | 29,000 | 50,000 | | Income Before Tax | (679,000) | 79,000 | 8,000 | 21,000 | | Income Tax Expense | (210,000) | 44,000 | 33,000 | 33,000 | | Minority Interest | (4,000) | 4,000 |
-
| 2,000 | | | | Net Income From Continuing Ops | (473,000) | 39,000 | (25,000) | (10,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (473,000) | 39,000 | (25,000) | (10,000) | | Preferred Stock And Other Adjustments | 7,000 | (2,000) | 2,000 |
-
| | | Net Income Applicable To Common Shares | ($466,000) | $37,000 | ($23,000) | ($10,000) |
|
2.03% Nasdaq 
Income Statement
